Syros Pharmaceuticals, Inc.

NasdaqGS:SYRS Stock Report

Mkt Cap: US$91.0m

Syros Pharmaceuticals Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average management tenure

CEO

Nancy Simonian (61 yo)

9.75yrs

Tenure

US$3,103,153

Compensation

Dr. Nancy A. Simonian, M.D., has been the Chief Executive Officer at Syros Pharmaceuticals, Inc. since July 2012 and serves as its President. Dr. Simonian had been Interim Principal Financial Officer and P...

CEO Compensation Analysis

How has Nancy Simonian's remuneration changed compared to Syros Pharmaceuticals's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$114m

Jun 30 2022n/an/a

-US$109m

Mar 31 2022n/an/a

-US$97m

Dec 31 2021US$3mUS$616k

-US$87m

Sep 30 2021n/an/a

-US$93m

Jun 30 2021n/an/a

-US$86m

Mar 31 2021n/an/a

-US$81m

Dec 31 2020US$3mUS$598k

-US$84m

Sep 30 2020n/an/a

-US$74m

Jun 30 2020n/an/a

-US$74m

Mar 31 2020n/an/a

-US$76m

Dec 31 2019US$4mUS$578k

-US$75m

Sep 30 2019n/an/a

-US$74m

Jun 30 2019n/an/a

-US$70m

Mar 31 2019n/an/a

-US$64m

Dec 31 2018US$3mUS$560k

-US$62m

Sep 30 2018n/an/a

-US$60m

Jun 30 2018n/an/a

-US$58m

Mar 31 2018n/an/a

-US$57m

Dec 31 2017US$2mUS$525k

-US$54m

Sep 30 2017n/an/a

-US$50m

Jun 30 2017n/an/a

-US$50m

Mar 31 2017n/an/a

-US$51m

Dec 31 2016US$2mUS$473k

-US$51m

Compensation vs Market: Nancy's total compensation ($USD3.10M) is above average for companies of similar size in the US market ($USD732.55K).

Compensation vs Earnings: Nancy's compensation has increased whilst the company is unprofitable.

Leadership Team

NamePositionTenureCompensationOwnership
Nancy Simonian
President10.5yrsUS$3.10m0.42%
$ 383.7k
Richard Young
Scientific Founderno dataUS$123.29k0.16%
$ 144.8k
Jason Haas
Chief Financial Officer1.25yrsUS$2.82mno data
David Roth
Chief Medical Officer7.08yrsUS$1.61m0.030%
$ 26.9k
James Bradner
Founderno datano datano data
Nathanael Gray
Scientific Founder & Member of Scientific Advisory Boardno datano datano data
Eric Olson
Chief Scientific Officer9.75yrsUS$1.18m0.030%
$ 26.9k
Courtney Solberg
Manager of Corporate Communications and Investor Relationsno datano datano data
Gerald Quirk
Chief Legal Officer0.25yrUS$1.46m0.043%
$ 39.1k
Christian Fritz
Head of Biologyno datano datano data
Kristin Stephens
Chief Development Officer2.58yrsno data0.015%
$ 13.9k
Conley Chee
Chief Commercial Officer1.33yrsno datano data

2.6yrs

Average Tenure

54yo

Average Age

Experienced Management: SYRS's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Nancy Simonian
President9.75yrsUS$3.10m0.42%
$ 383.7k
Richard Young
Scientific Founder11.17yrsUS$123.29k0.16%
$ 144.8k
Nathanael Gray
Scientific Founder & Member of Scientific Advisory Board9.75yrsno datano data
Peter Wirth
Independent Chairman6yrsUS$153.29k0.0040%
$ 3.6k
Mark Murcko
Member of Scientific Advisory Board9.75yrsno datano data
Marsha Fanucci
Independent Director7.25yrsUS$128.29k0.0040%
$ 3.6k
Gerard Evan
Member of Scientific Advisory Board9.75yrsno datano data
Scott Biller
Member of Scientific Advisory Board9.75yrsno datano data
Bradley Bernstein
Member of Scientific Advisory Boardno datano datano data
Stefan Knapp
Member of Scientific Advisory Board9.75yrsno datano data
Aviv Regev
Member of Scientific Advisory Board9.75yrsno datano data
Chris Vakoc
Member of Scientific Advisory Board9.75yrsno datano data

9.8yrs

Average Tenure

66yo

Average Age

Experienced Board: SYRS's board of directors are considered experienced (9.8 years average tenure).